Trials / Completed
CompletedNCT05320861
Single Dose ADME Study of [14C]SJP-0008 in Healthy Male Subjects
A Single Dose Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism and Excretion of [14C]SJP-0008 in Healthy Male Subjects After an Oral Dose
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Senju Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This single centre, open-label, non-randomised, single period, single-dose study in healthy male subjects was designed and conducted to assess the mass balance recovery, PK, metabolite profile and metabolite identification of SJP-0008.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]SJP-0008 | Single oral dose of \[14C\]SJP-0008 |
Timeline
- Start date
- 2021-09-24
- Primary completion
- 2021-11-02
- Completion
- 2021-11-02
- First posted
- 2022-04-11
- Last updated
- 2022-04-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05320861. Inclusion in this directory is not an endorsement.